浙江交科(002061.SZ):中標G2531杭州至上饒高速公路(杭淳開高速公路)杭州中環至浙贛界(衢州段)相關標段
格隆匯7月25日丨浙江交科(002061.SZ)公佈,公司於2025年07月08日在《證券時報》《證券日報》《上海證券報》及巨潮資訊網上披露了《關於擬中標項目的提示性公吿》,下屬公司浙江交工金築交通建設有限公司、浙江交工集團股份有限公司、浙江交工宏途交通建設有限公司分別為G2531杭州至上饒高速公路(杭淳開高速公路)杭州中環至浙贛界(衢州段)第TJ01、TJ03、TJ04標段第一中標候選人。近日,公司收到下屬公司發來的上述項目中標通知書。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.